Stocklytics Platform
Asset logo for symbol ZTS
Zoetis
ZTS58
$162.23arrow_drop_up0.19%$0.31
S&P500
Asset logo for symbol ZTS
ZTS58

$162.23

arrow_drop_up0.19%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
Industry average yield2.89%
Last Dividend pay dateJun 3, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Analyst rating

An aggregate view of professional's ratings.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Stock Performance

ZTS-
US Healthcare Sector-
US Market-
check_circle

ZTS / Market

ZTS exceeded the US Market which returned 0.03% over the last twenty four hours.
warning

ZTS / Healthcare Sector

ZTS lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Zoetis (ZTS) Statistics

Zoetis Inc (ZTS) is a leading global animal health company that focuses on discovering, developing, manufacturing, and marketing veterinary vaccines, medicines, and diagnostic products. With a strong portfolio of products and a presence in over 100 countries, Zoetis is well-positioned to serve the growing demand for animal health products worldwide. As of [insert date], the stock for Zoetis Inc (ZTS) has been performing consistently well, outperforming the broader sector in terms of stock performance.
When it comes to valuation metrics, Zoetis Inc (ZTS) has shown positive indicators. The company's fundamentals are strong, with a healthy revenue per share and a favorable Enterprise to EBITDA ratio. The revenue per share for Zoetis Inc (ZTS) reflects the revenue generated by the company for each outstanding share of common stock. This metric provides insights into the efficiency of the company's operations and its ability to generate revenue. Moreover, the Enterprise to EBITDA ratio, a measure of the company's ability to generate operating profits relative to its overall debt burden, is also favorable for Zoetis Inc (ZTS).
add Zoetis to watchlist

Keep an eye on Zoetis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Zoetis (ZTS) stock's performance compared to its sector and the market over the past year?

Over the past year, Zoetis (ZTS) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Zoetis has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Zoetis 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Zoetis (ZTS) stock?

The PE (Price to Earnings) ratio of Zoetis (ZTS) is currently 29.66. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Zoetis (ZTS) stock?

The Earnings Per Share (EPS) for Zoetis (ZTS), calculated on a diluted basis, is $5.47. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Zoetis (ZTS) stock?

The operating margin for Zoetis (ZTS) is 33.06%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Zoetis (ZTS) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Zoetis (ZTS) is $4B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Zoetis (ZTS) have?

Zoetis (ZTS) has a total debt of $6.83B. The net debt, which accounts for cash and cash equivalents against the total debt, is $4.76B.

Take Your Investments to a Whole New Level